These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8106649

  • 21. Direct cost of depression: analysis of treatment costs of paroxetine versus Imipramine in Canada.
    Lapierre Y, Bentkover J, Schainbaum S, Manners S.
    Can J Psychiatry; 1995 Sep; 40(7):370-7. PubMed ID: 8548716
    [Abstract] [Full Text] [Related]

  • 22. An early clinical phase II evaluation of paroxetine, a new potent and selective 5HT-uptake inhibitor in patients with depressive illness.
    Børup C, Meidahl B, Petersen IM, Vangtorp A, le Fèvre Honoré P.
    Pharmacopsychiatria; 1982 Nov; 15(6):183-6. PubMed ID: 6218507
    [Abstract] [Full Text] [Related]

  • 23. Cardiovascular effects of antidepressants: studies of paroxetine in healthy men and depressed patients.
    Warrington SJ, Lewis Y.
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():59-64. PubMed ID: 1431013
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL, Clissold SP.
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [Abstract] [Full Text] [Related]

  • 27. Antidepressant treatment and global tests of coagulation and fibrinolysis.
    Lederbogen F, Weber B, Colla M, Heuser I, Deuschle M, Dempfle CE.
    J Clin Psychiatry; 2001 Feb; 62(2):130. PubMed ID: 11247103
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of paroxetine on seizure length during electroconvulsive therapy.
    Curran S.
    Acta Psychiatr Scand; 1995 Sep; 92(3):239-40. PubMed ID: 7484206
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The advantages of paroxetine in different subgroups of depression.
    Montgomery SA.
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():91-100. PubMed ID: 1431017
    [Abstract] [Full Text] [Related]

  • 36. A study comparing paroxetine placebo and imipramine in depressed patients.
    Feighner JP, Cohn JB, Fabre LF, Fieve RR, Mendels J, Shrivastava RK, Dunbar GC.
    J Affect Disord; 1993 Jun; 28(2):71-9. PubMed ID: 8354771
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serotonin syndrome: case report and review of the literature.
    Weiner AL, Tilden FF, McKay CA.
    Conn Med; 1997 Nov; 61(11):717-21. PubMed ID: 9419960
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.